Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast CancerPrudence A. Francis, Meredith M. Regan, Olivia Pagani et al.|New England Journal of Medicine|2018Cited by 684
Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor®) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical studyGilbert Donders, Stefan Buchholz, Patrick Neven et al.|Breast Cancer Research and Treatment|2014Cited by 128
Vaginal estriol–lactobacilli combination and quality of life in endocrine-treated breast cancerStefan Buchholz, Gilbert Donders, Gert Bellen et al.|Climacteric|2014Cited by 46
Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitorsGilbert Donders, Olaf Ortmann, Gert Bellen et al.|European Journal of Clinical Microbiology & Infectious Diseases|2015Cited by 43
Abstract P2-12-06: Ultra-low dose vaginal estriol and Lactobacillus acidophilus (Gynoflor®) in early breast cancer survivors on aromatase inhibitors: Pharmacokinetic, efficacy and safety results from a phase I study.Patrick Neven, Stefan Buchholz, Gilbert Donders et al.|Cancer Research|2012Cited by 2